
pmid: 13787479
Summary and Conclusions A strain of Plasmodium falciparum from the Magdalena Valley, Colombia, South America, which is resistant to chloroquine, has been shown to be resistant also to amodiaquine (Camoquin®) and to hydroxychloroquine (Plaquenil®), which are other members of the 4-aminoquinoline group. The resistant quality persisted after mosquito passage. The infections responded to quinine and to mepacrine, but relapses occurred. In areas where there is resistance to one of the above 4-aminoquinolines, it would appear unwise to depend upon another of the group for treatment, especially in acute cases; until evidence to the contrary is found, it seems desirable to use some other drug, perhaps quinine or mepacrine.
Antimalarials, Plasmodium falciparum, Amodiaquine, Humans, Chloroquine, Hydroxychloroquine, Malaria
Antimalarials, Plasmodium falciparum, Amodiaquine, Humans, Chloroquine, Hydroxychloroquine, Malaria
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 48 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
